By FnF Correspondent | PUBLISHED: 27, Apr 2021, 18:19 pm IST | UPDATED: 27, Apr 2021, 18:22 pm IST
Reuters in its report quoted Ana Carolina Moreira Marino Araujo, general manager for health monitoring, stating that technical staff had highlighted "inherent risks" and "serious" defects, citing a lack of information guaranteeing its safety, quality and effectiveness.
Gustavo Mendes, the medicines and biological products manager of Anvisa, confirmed the development saying that the board noticed a crucial issue - the presence of adenovirus in the vaccine, which could produce a "serious" defect.
About 14 states in Brazil had appealed for an urgent import of Sputnik to counter a growing wave of COVID-19 infections. According to the latest data available, the country has over 14 million recorded cases with a death toll approaching 400,000.
Russian made Sputnik V covid-19 vaccine has been approved in several countries around the world with scientists claiming 97.6% effective against the deadly virus against Covid-19 in a "real-world" assessment based on data from 3.8 million people.
by : Priti Prakash
The farmers have marched back to Delhi with their demands, for which they sat on roads leading to th...